Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 33 Records) |
| Query Trace: Lung Neoplasms and meta-analysis and MET[original query] |
|---|
| Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation. Health technology assessment (Winchester, England) 2013 Jul 17 (31): 1-278. Brown T, Pilkington G, Bagust A, Boland A, Oyee J, Tudur-Smith C, Blundell M, Lai M, Martin Saborido C, Greenhalgh J, Dundar Y, Dickson |
| Cytochrome P450 2A6 deletion polymorphism and risk of lung cancer: a meta-analysis. Molecular biology reports 2013 Sep 40 (9): 5255-9. Liu Zheng-Bing, Shu Jun, Wang Li-Ping, Jin Cheng, Lou Zhi-X |
| Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trials. OncoTargets and therapy 2013 1771-7. Zhang Yiliang, Sun Yihua, Wang Lei, Ye Ting, Pan Yunjian, Hu Haichuan, Yu Yongfu, Zhao Naiqing, Song Yanyan, Garfield David, Chen Haiqu |
| Erlotinib in wild type epidermal growth factor receptor non-small cell lung cancer: A systematic review. Annals of thoracic medicine 2013 Oct 8 (4): 204-8. Jazieh Abdul-Rahman, Al Sudairy Reem, Abu-Shraie Nada, Al Suwairi Wafaa, Ferwana Mazen, Murad M Hass |
| A literature-based systematic HuGE review and meta-analysis show that CASP gene family polymorphisms are associated with risk of lung cancer. Genetics and molecular research : GMR 2013 Jan 12 (AOP): AOP. Zhang ZY, Xuan Y, Jin XY, Tian X, Wu R |
| No significant association between the XRCC3 Thr241Met polymorphism and lung cancer risk: a meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Apr 34 (2): 865-74. Xu Yun-Hua, Gu Lin-Ping, Sun Ying-Jia, Cheng Bai-Jun, Lu Sh |
| MET gene copy number predicts worse overall survival in patients with non-small cell lung cancer (NSCLC); a systematic review and meta-analysis. PloS one 2014 9 (9): e107677. Dimou Anastasios, Non Lemuel, Chae Young Kwang, Tester William J, Syrigos Konstantinos |
| Diagnostic value of mutation-specific antibodies for immunohistochemical detection of epidermal growth factor receptor mutations in non-small cell lung cancer: a meta-analysis. PloS one 2014 9 (9): e105940. Chen Zi, Liu Hong-bing, Yu Chun-hua, Wang Ying, Wang Li, Song Yo |
| Meta analysis of XRCC3 Thr241Met polymorphism and lung cancer susceptibility of populations in East Asia. Asian Pacific journal of tropical medicine 2014 Jun 7 (6): 483-7. Xing Zhi-Song, Zhu Guang, Yang Yu-Lun, Feng Guang-Qiang, Ding Guang-Che |
| Prognostic value of MET gene copy number and protein expression in patients with surgically resected non-small cell lung cancer: a meta-analysis of published literatures. PloS one 2014 9 (6): e99399. Guo Baoping, Cen Hong, Tan Xiaohong, Liu Wenjian, Ke Qi |
| Role of MDM2 T309G polymorphism in susceptibility and prognosis of nonsmall cell lung cancer: a meta-analysis. Genetic testing and molecular biomarkers 2014 May 18 (5): 357-65. Kong Qian, Li Ping, Tian Qiong, Ha Min-W |
| Association between HIF-1a C1772T/G1790A polymorphisms and cancer susceptibility: an updated systematic review and meta-analysis based on 40 case-control studies. BMC cancer 2014 14 950. Yan Qing, Chen Pin, Wang Songtao, Liu Ning, Zhao Peng, Gu Aih |
| Association between Catechol-O-methyltransferase rs4680 (G>A) polymorphism and lung cancer risk. Diagnostic pathology 2014 9 192. Tan Xiang, Chen Ming |
| Association between the TERT Genetic Polymorphism rs2853676 and Cancer Risk: Meta-Analysis of 76,108 Cases and 134,215 Controls. PloS one 2015 10 (6): e0128829. Cao Jin-Lin, Yuan Ping, Abuduwufuer Abudumailamu, Lv Wang, Yang Yun-Hai, Hu Ji |
| KRAS mutation is a weak, but valid predictor for poor prognosis and treatment outcomes in NSCLC: A meta-analysis of 41 studies. Oncotarget 2016 Jan . Pan Wei, Yang Yan, Zhu Hongcheng, Zhang Youcheng, Zhou Rongping, Sun Xinch |
| Evaluation of Prediction of Polymorphisms of DNA Repair Genes on the Efficacy of Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer: A Network Meta-Analysis. Journal of cellular biochemistry 2017 12 118 (12): 4782-4791. Yu Shao-Nan, Liu Gui-Feng, Li Xue-Feng, Fu Bao-Hong, Dong Li-Xin, Zhang Shu-H |
| Clinicopathological implications of MET exon 14 mutations in non-small cell lung cancer - A systematic review and meta-analysis. Lung cancer (Amsterdam, Netherlands) 2018 8 123 76-82. Vuong Huy Gia, Ho An Thi Nhat, Altibi Ahmed M A, Nakazawa Tadao, Katoh Ryohei, Kondo Tets |
| Comparative Efficacy of Treatments for Previously Treated Advanced or Metastatic Non-Small-Cell Lung Cancer: A Network Meta-Analysis. Advances in therapy 2018 6 35 (7): 1035-1048. Li Junlong, Sasane Medha, Zhao Jing, Horton Viviana Garcia, Zhang Pingkuan, Ricculli Marie Louise, Zhou Zheng-Yi, Signorovitch Jam |
| Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis. Journal of Cancer 2018 9 (10): 1836-1845. Kim Jung Han, Kim Hyeong Su, Kim Bum J |
| Association between PD-L1 expression and driver gene status in non-small-cell lung cancer: a meta-analysis. Oncotarget 2018 Jan 9 (7): 7684-7699. Lan Bo, Ma Chengxi, Zhang Chengyan, Chai Shoujie, Wang Pingli, Ding Liren, Wang K |
| Association of MDM2 gene SNP 309 polymorphism and human non-small cell lung cancer susceptibility: A meta-analysis. Pathology, research and practice 2019 Jul 152538. Luan Lan, Wang Hongying, Zhao Beibei, Wang Fan, Shi Juan, Xu Xiaj |
| Prognostic value of receptor tyrosine kinase-like orphan receptor (ROR) family in cancer: A meta-analysis. Cancer treatment reviews 2019 6 77 11-19. Saleh Ramy R, Antrás Jesús Fuentes, Peinado Paloma, Pérez-Segura Pedro, Pandiella Atanasio, Amir Eitan, Ocaña Alber |
| CT and clinical characteristics that predict risk of EGFR mutation in non-small cell lung cancer: a systematic review and meta-analysis. International journal of clinical oncology 2019 Mar . Zhang Hanfei, Cai Weiguo, Wang Yanfan, Liao Meiyan, Tian Sufa |
| ATM rs189037 (G?>?A) polymorphism increased the risk of cancer: an updated meta-analysis. BMC medical genetics 2019 Feb 20 (1): 28. Zhao Zhi-Liang, Xia Lu, Zhao Cong, Yao J |
| Association between the combined effects of GSTM1 present/null and CYP1A1 MspI polymorphisms with lung cancer risk: an updated meta-analysis. Bioscience reports 2020 Sep . Zhang Wen-Ping, He Xiao-Feng, Ye Xiang-H |
| Genetic Polymorphisms and Platinum-Based Chemotherapy-Induced Toxicities in Patients With Lung Cancer: A Systematic Review and Meta-Analysis. Frontiers in oncology 2020 4 9 1573. Liu Wenhui, Wang Ying, Luo Jianquan, Yuan Haiyan, Luo Zhiyi |
| Crizotinib Versus Conventional Chemotherapy in First-Line Treatment for ALK-Positive Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Oncology and therapy 2021 6 9 (2): 505-524. Cruz Barbara D, Barbosa Mariana M, Torres Lucas L, Azevedo Pamela S, Silva Vânia E A, Godman Brian, Alvares-Teodoro Julia |
| Driver Genes Associated With the Incidence of Venous Thromboembolism in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. Frontiers in oncology 2021 5 11 680191. Qian Xiaohan, Fu Mengjiao, Zheng Jing, Zhou Jianya, Zhou Jianyi |
| Optimal Treatments for NSCLC Patients Harboring Primary or Acquired MET Amplification. Technology in cancer research & treatment 2022 9 21 15330338221128414. Sun Dantong, Tao Junyan, Yan Weihua, Zhu Jingjuan, Zhou Hai, Sheng Yingying, Xue Chaofan, Li Hong, Hou Hel |
| Clinical and CT patterns to predict EGFR mutation in patients with non-small cell lung cancer: A systematic literature review and meta-analysis. European journal of radiology open 2022 2 9 100400. Ortiz Andrés Felipe Herrera, Camacho Tatiana Cadavid, Vásquez Andrés Francisco, Del Castillo Herazo Valeria, Neira Juan Guillermo Arámbula, Yepes María Mónica, Camacho Eduard Cadav |
- Page last reviewed:Feb 1, 2024
- Content source: